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Non-union is deﬁned as the permanent failure of a bone to heal and occurs clinically in 5% of
fractures. Atrophic non-unions, characterized by absent/minimal callus formation, are poorly
understood and difﬁcult to treat. We recently demonstrated a novel murine model of atrophic
non-union in the 3.6Col1A1-tk (Col1-tk) mouse, wherein dosing with the nucleoside analog
ganciclovir (GCV) was used to deplete proliferating osteoprogenitor cells, leading to a
radiographic and biomechanical non-union after the mid-shaft femur fracture. Using this
Col1-tk atrophic non-union model, we hypothesized that the scaffold-mediated lentiviral
delivery of doxycycline-inducible BMP-2 transgenes would induce osteogenesis at the
fracture site. Cryogel scaffolds were used as a vehicle for GFP+ and BMP-2+ cell delivery to
the site of non-union. Cryogel scaffolds were biofabricated through the cross-linking of a
chitosan–gelatin polymer solution at subzero temperatures, which results in a macroporous,
spongy structure that may be advantageous for a bone regeneration application. Murine
adipose-derived stem cells were seeded onto the cryogel scaffolds, where they underwent
lentiviral transduction. Following the establishment of atrophic non-unions in the femurs of
Col1-tk mice (4 weeks post-fracture), transduced, seeded scaffolds were surgically placed
around the site of non-union, and the animals were given doxycycline water to induce BMP2 production. Controls included GFP+ cells on the cryogel scaffolds, acellular scaffolds, and
sham (no scaffold). Weekly radiographs were taken, and endpoint analysis included microCT and histological staining. After 2 weeks of implantation, the BMP-2+ scaffolds were
inﬁltrated with cartilage and woven bone at the non-union site, while GFP+ scaffolds had
woven bone formation. Later, timepoints of 8 weeks had woven bone and vessel formation
within the BMP-2+ and GFP + scaffolds with cortical bridging of the original fracture site in
both groups. Overall, the cell-seeded cryogels promoted osseous healing. However, while
the addition of BMP-2 promoted the endochondral ossiﬁcation, it may provide a slower
route to healing. This proof-of-concept study demonstrates the potential for cellularized
cryogel scaffolds to enhance the healing of non-unions.
Keywords: animal models, fracture healing, tissue engineering, cryogels, BMP-2
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INTRODUCTION

Cryogels are hydrogel-based scaffolds that have enhanced
porosity and mechanical properties due to the addition of a
freezing process during fabrication (Henderson et al., 2013;
Hixon et al., 2017a; Bakhshpour et al., 2019). Brieﬂy, following
the cross-linking of a polymer solution, the mixture is
immediately frozen, resulting in the formation of ice crystals
throughout the solution. Upon thawing and melting of these ice
crystals, the resulting polymer structure is macroporous, spongelike, and mechanically durable (Henderson et al., 2013; Okay,
2014). Previous studies have demonstrated that cryogels are
suitable for the treatment of complex bone defects including
critical size defects in both long bones and craniofacial
applications (Dumas et al., 2012; Mishra et al., 2014; Hixon
et al., 2017b). However, their application to enhance the repair
of atrophic non-unions has not been previously investigated.
While tissue engineering approaches have an excellent capability
to promote both tissue repair and regeneration of bone injury,
further modiﬁcation can improve their applicability in treating
more complex bone defects (e.g., atrophic non-unions, where
biological healing has been disrupted) through the ability to
deliver speciﬁc cell types and/or growth factors. Previous
studies have developed woven polymer scaffolds capable of
mediating stem cell differentiation and cartilaginous
extracellular matrix (ECM) formation using a lentivirus-based
method (Brunger et al., 2014; Glass et al., 2014). Subsequent work
developed scaffold-mediated lentiviral gene delivery of bone
morphogenetic protein-2 (BMP-2), a potent osteogenic factor
(Rowland et al., 2018). While woven ﬁber scaffolds are favorable
for tissue-engineered cartilage applications, cryogel scaffolds offer
a promising alternative for in situ bone regeneration due to their
macroporous structure and high pore interconnectivity, which
allows ﬂuid ﬂow, cell mobility, and angiogenesis (Hixon et al.,
2016; Bakhshpour et al., 2019). Speciﬁcally, chitosan–gelatin
cryogels are composed of natural materials and have been
extensively characterized with pore diameters ranging from 30
to 100 μm conducive to cell inﬁltration (Kathuria et al., 2009).
The combination of cryogel scaffolds with a lentivirus-based
method holds the potential to induce bone formation and
healing (Rodrigues et al., 2013; Liao et al., 2016; Kemençe and
Bölgen, 2017). We focused on the local delivery of BMP-2, long
recognized as a potent osteoinductive growth factor capable of
improving healing of non-unions, fractures, spinal fusions, and
dental implants (Lo et al., 2012; Krishnakumar et al., 2017).
Previous studies have shown that following the stabilization of a
fracture, exogenous BMP-2 induces cartilage formation and can
promote endochondral ossiﬁcation. Furthermore, the periosteum
has been shown to be a target of exogenous BMP-2 (Yu et al.,
2010). Notably, previous studies have focused on cellular
engineering approaches, including the engineering of
mesenchymal stem cells (MSCs) to express BMP-2 in
combination with vascular endothelial growth factor (VEGF)
or mineral-coated microparticles (Kumar et al., 2010; Orth
et al., 2017). Such approaches have demonstrated osseous
bridging and increased bone formation. Despite this, the
treatment of atrophic non-union can be challenging where the
tunable delivery of a biological agent, along with a scaffold matrix,
is necessary for appropriate, localized treatment to encourage cell

Non-union is deﬁned as the permanent failure of a bone to heal
and occurs clinically in approximately 5% of all fractures
(Einhorn, 1995; Choi et al., 2004). With increased risk due to
factors such as sex, smoking, and diabetes, currently available
invasive surgical treatments result in major physical and ﬁnancial
burdens on individuals (Zura et al., 2016; Mills et al., 2017; Dailey
et al., 2018; Ekegren et al., 2018). Among the several types of nonunions, atrophic non-unions, characterized by absent/minimal
osteochondral callus formation, are poorly understood and
difﬁcult to treat (Mills and Simpson, 2012; Thomas and
Kehoe, 2021). Furthermore, in atrophic non-unions, bone
healing has become stagnant, and surgical intervention with
the addition of a biological agent, such as a bone graft, is
often necessary to induce regeneration (Moghaddam et al.,
2016; Sun et al., 2019). While autografts remain the gold
standard for treatment, there are inherent disadvantages
including potential for infection, donor site morbidity, and
limited availability (Roberts and Rosenbaum, 2012; Sohn and
Oh, 2019).
Animal models of atrophic non-unions have been described in
mice (Choi et al., 2004; Lu et al., 2007; Garcia et al., 2008; Garcia
et al., 2011; Wang et al., 2019), rats (Cullinane et al., 2002;
Harrison et al., 2003; Kokubu et al., 2003; Reed et al., 2003;
Schmidhammer et al., 2006; Kaspar et al., 2008; Tawonsawatruk
et al., 2014; Roberto-Rodrigues et al., 2015), and rabbits (Oni,
1995; Brownlow and Simpson, 2000; Park et al., 2002). Most
available models target fracture healing by disrupting the tissues
needed for repair through invasive methods such as osteotomy,
periosteal stripping, and/or devascularization (Mills and
Simpson, 2012; Gómez-Barrena et al., 2015; Panteli et al.,
2015). While such methods do yield an atrophic non-union,
they do not model some clinical atrophic non-unions, which
occur without extensive tissue damage and are attributed to
“failure of biology.” We recently developed a novel murine
model of atrophic non-union in the 3.6Col1A1-tk (Col1-tk)
mouse, where dosing with the nucleoside analog ganciclovir
(GCV) is used to deplete replicating osteoblast lineage cells
(Hixon et al., 2021). Brieﬂy, in proliferating cells that express
the thymidine kinase (tk) “suicide gene,” GCV is converted to a
toxic nucleotide, which is then incorporated into the DNA. This
results in targeted death of dividing tk + cells, which prevents the
proliferative expansion needed to form a callus, leading to callus
formation failure after the fracture and thus radiographic and
biomechanical non-union. Notably, because non-dividing cells
are spared, the fracture site is still populated by viable cells
including, presumably, skeletal progenitors. Once GCV is
withdrawn, there is potential for these resident cells to
proliferate and contribute to fracture healing, although our
prior work showed that this does not happen spontaneously
(Hixon et al., 2021). This biologically relevant model allows for
the testing of novel intervention techniques that might reactivate
the quiescent native cells to rescue an atrophic non-union.
Tissue engineering scaffolds provide a promising alternative to
currently used bone grafts due to their tailorable properties to
modify porosity, mechanical integrity, and degradation rate.
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FIGURE 1 | Schematic of the establishment of a non-union and scaffold implantation in Col1-tk mice. (A) While receiving the GCV drug, any Col1-tk + cells within
the mouse that are proliferating will selectively die. Non-proliferating osteoblasts will remain alive. Once the drug is removed, any proliferating osteoblasts will not die. (B,
C) Col1-tk mice at 12 weeks of age were subjected to a femur fracture, followed by daily GCV administration for 2 weeks to blunt the healing response. The mice were
monitored from week 1–4 by X-ray to conﬁrm minimal callus formation. At 4 weeks post-fracture, an additional surgery was performed, and the scaffolds were
implanted. The mice were monitored by X-ray for 2–8 weeks post-scaffold implantation until sacriﬁce. The outcomes included micro-CT and histology.

inﬁltration and initiate healing. Additionally, the exclusively
uncontrolled delivery of growth factors such as BMP-2, as well
as delivery methods without tunability, can have deleterious
results such as excessive heterotopic ossiﬁcation or increased
cancer risk (Shi et al., 2013; Skovrlj et al., 2015; Shi et al., 2017).
Thus, we used a doxycycline-inducible BMP-2 lentivirus for the
tunable and inducible delivery of BMP-2 in an adipose stem cellseeded scaffold to the non-union site. The viral vector has been
shown to have a high transduction efﬁciency and result in an
inducible production of BMP-2 when exposed to doxycycline
(Glass et al., 2014; Rowland et al., 2018). In combination with the
biologically relevant Col1-tk mouse model of atrophic nonunion, this treatment method allows for the testing of a novel
intervention technique to rescue fracture non-union. We
hypothesize that the tissue-engineered scaffold-mediated gene
delivery of a cell population overexpressing the osteogenic
transgene BMP-2 will induce osteogenesis at the site of nonunion. Previous work has demonstrated that scaffold-mediated
gene delivery can induce sustained transgene expression and
ECM formation by MSCs (Kokubu et al., 2003; Hixon et al.,
2016; Hixon et al., 2017a; de Lageneste et al., 2018), and we
anticipate that using this approach with BMP-2 will provide the
osteoinductive environment necessary to drive periosteal healing.

skin; Sigma) was added to the solution and mixed for 1 h. In a
separate scintillation vial, 1% glutaraldehyde solution was
prepared using 2 ml of 1% acetic acid solution for crosslinking. All the solutions were cooled at 4°C for 1 h. The
solutions were mixed by decanting and then immediately
poured into precooled 12-well plates (Sigma), such that a
thickness of 3–4 mm was achieved, and frozen at −20°C for
18 h. At this time, the plates were thawed at room
temperature (RT) water and trimmed into rectangular sheets
(6 mm × 12 mm × 1.5 mm). The scaffolds were sterilized in 1%
peracetic acid (PAA; Sigma) for 90 min and then rinsed with
sterile 1X phosphate-buffered saline (PBS) three times for 10 min
(Yoganarasimha et al., 2014; Costa et al., 2015). Following
sterilization, all the scaffolds were placed at −80°C for 1 h and
subsequently lyophilized (Sentry 2.0 VirTis BenchTop Pro Freeze
Dryer; SP Scientiﬁc) for 24 h to ensure complete drying. The
resulting cryogel scaffolds were macroporous (pore diameters of
30–100 μm) and sponge-like in structure, allowing them to
undergo compression without the crack propagation (Brunger
et al., 2014; Gómez-Barrena et al., 2015). Additionally, the
cryogels were fabricated from the natural materials that render
them compatible with cells and supportive of angiogenesis (Glass
et al., 2014).

Lentivirus Production
MATERIALS AND METHODS

The doxycycline-inducible lentiviral vector was generated by
cloning BMP2 into the modiﬁed TMPrtTA vector (provided
by Danos Lab) as previously described (Rowland et al., 2018).
To produce the lentivirus, HEK293T cells were co-transfected
with either the dox-BMP2 vector or a constitutive GFP lentiviral
vector with a second-generation packaging plasmid psPAX2
(Addgene, No. 12260) and an envelope plasmid pMD2.G
(Addgene, No. 12259) by calcium phosphate precipitation

Scaffold Fabrication
Cryogel scaffolds (n = 4/group/timepoint) were fabricated based
on a previously established protocol (Kathuria et al., 2009).
Brieﬂy, 80 mg of low-viscosity chitosan (MP Biomedicals) was
dissolved in 8 ml of 1% acetic acid solution (Fisher Scientiﬁc).
Following dissolution, 320 mg of gelatin (from cold water ﬁsh
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(Salmon and Trono, 2007). The lentivirus was stored at –80°C
until further use. The functional titer of each virus was
determined via qRT-PCR to ascertain the number of lentiviral
DNA copies integrated into the genome of the transduced HeLa
cells (Salmon and Trono, 2007). On the day of transduction, the
lentivirus was thawed and concentrated ~100-fold using Amicon
Ultra 100 kDa MWCO ﬁlters (Millipore, UFC9100).

and Use Committee (IACUC) at Washington University in St.
Louis in accordance with the Animal Welfare Act and PHS Policy
on Humane Care and Use of Laboratory Animals. Atrophic nonunions were established in transgenic 3.6Col1A1-tk (Col1-tk)
mice (rederived from the frozen embryos provided by Drs. Robert
Jilka and Charles O’Brien) by targeting the replicating osteoblast
progenitors (Jilka et al., 2009). As these mice express the herpes
simplex virus thymidine kinase gene (HSV-tk, or “tk”), driven by
the 3.6-kb rat Col1A1 promoter which is active in the osteoblast
lineage cells; the addition of the nucleoside analog ganciclovir
(GCV) targets replicating osteoblast progenitors (Figure 1A).
This process occurs through the conversion of GCV to a toxic
version of the nucleotide which is incorporated into the DNA,
resulting in strands breaking and cell apoptosis (Jilka et al., 2009).
To generate Col1-tk mice, male C57BL6/J (The Jackson
Laboratory, #000664) mice were bred with female mice,
heterozygous for the tk transgene (tk-positive). This resulted
in the heterozygous tk-positive (Col1-tk) and tk-negative
(wild-type, WT) mice. Only one allelic copy of the tk
transgene is necessary to achieve the tk-positive and the male
Col1-tk mice are sterile. All genotyping procedures were
completed by Transnetyx (Cordova, TN) from toe biopsies
taken from the mice for the real-time PCR (probe: puro).
Additional breeding was used in the littermates (tk-positive
females and tk-negative males). Prior to and during the
experimental procedures, all the mice were group-housed (up
to ﬁve mice/cage) under standard 12-h light/dark cycles with full
access to food and water. Note that breeders were given high-fat
chow, but following weaning, the experimental mice were given
normal chow. All the mice were dosed with ganciclovir (GCV,
8 mg/kg i.p., McKesson) once daily starting at the fracture
(12 weeks of age) for 2 weeks. The mice were euthanized by
CO2 asphyxiation at designated endpoints from 6 to 12 weeks
after the fracture.

Scaffold-Mediated Lentiviral Transduction
To immobilize the lentivirus on the scaffolds, cryogels (n = 4/
group/timepoint) were incubated overnight with 0.002% poly-Llysine (Sigma), washed with PBS, and then incubated with
enough concentrated lentivirus to transduce 500,000 or 1
million cells for 1.5 h at 37°C. The scaffolds were rinsed again
with PBS, moved to a new low-attachment 24-well plate
(Corning), and seeded with 500,000 cells for in vitro
experiments and 1 million cells for implanted scaffolds. The
expansion medium was added to each sample for 1 h after the
cell seeding. All mediums were changed 24 h later. The scaffolds
were cultured in the expansion medium for six days to facilitate
cell inﬁltration. A subset of scaffolds were then ﬁxed in a neutralbuffered formalin (NBF) for 24 h, placed in a 30% sucrose
solution for an additional 24 h, and embedded in an optimal
cutting temperature (OCT) compound. Once frozen, the cryogels
were cryosectioned at 20 µm and stained with 4′,6-diamidino-2phenylindole (DAPI) to visualize the cellular inﬁltration. All
other scaffolds remained in culture.

In Vitro BMP-2 Analysis
After 6 days of culture in the expansion medium, the medium was
changed to osteogenic medium containing DMEM-HG (Gibco),
10% lot selected FBS, 1% penicillin–streptomycin (Gibco), 50 μg/
ml L-ascorbic acid 2-phosphate (Sigma), 10 nM dexamethasone
(Sigma), and 10 mM β-glycerophosphate (Sigma). Doxycycline
(dox) groups were supplemented with either 0.1 or 1 μg/ml dox
(Sigma). Half medium changes were performed every other day
for 28 days, and medium samples were collected on days 0, 2, 6,
10, 16, 22, and 28 of the osteogenic culture. The concentration of
BMP-2 in the medium (n = 4/group/timepoint) was measured by
ELISA (R&D).

Establishment of the Non-Union
We recently demonstrated a model of atrophic non-union in
Col1-tk mice dosed with GCV (Hixon et al., 2021). Brieﬂy, a
previously established protocol was employed to create a full
fracture in the right femur of 12-week-old mice (Gardner et al.,
2011). All mice were given buprenorphine SR (1 mg/kg, s.c.) for
analgesia 1 h before surgery. The fracture was created by applying
a transverse force across the right femoral mid-diaphysis using a
custom 3-pt bending setup (DynaMight 8841; Instron). The
femur was then stabilized using a 24-gauge metal pin
(MicroGroup), and the incision was closed using 3-0 nylon
sutures (Ethicon). We conﬁrmed proper ﬁxation by
radiography (Faxitron Ultrafocus 100; Faxitron Bioptics)
immediately following the fracture surgery. Note that in the
WT mice, this model closely mirrors the classic fracture injury
and healing response (Einhorn, 1998; Bonnarens and Einhorn,
1984), displaying both endochondral and intramembranous
healing within the fracture gap and around the periphery,
respectively (Liu et al., 2017; McKenzie et al., 2019). To
establish the atrophic non-union, Col1-tk mice were dosed
with GCV at the time of bone injury for 2 weeks, at which
time the drug was withdrawn. All the animals were then

Scaffold Micro-CT Analysis
Following 28 days of osteogenic culture, the scaffolds (n = 4/
group/timepoint) were scanned using the Bruker SkyScan
1176 micro-CT at 40 V, 600 µA. Micro-CT datasets were
reconstructed with NRecon software using a dynamic range of
0.1, ring artifact correction of 11, and beam hardening correction
of 20%. Mineralization was quantiﬁed via calibration against
hydroxyapatite phantoms using CT-Analyzer software.
Acellular scaffolds soaked in the medium for 28 days served as
a control.

Mouse Lines
A total of 62 male and female mice at 12 weeks of age were used in
one of the four experimental groups: sham, scaffold only, GFP
cells + scaffold, and BMP-2 cells + scaffold. Experimental
procedures were approved by the Institutional Animal Care
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monitored by weekly radiography (Faxitron) for an additional
2 weeks to conﬁrm a lack of bone formation and healing response,
consistent with a non-union (4 weeks following fracture surgery;
Figures 1B,C). Dosing, withdrawal, and revision surgery
timepoints were based on the previous work in this mouse
line and cover the established bridging window in the control
mice (Garcia et al., 2013; Liu et al., 2017; Hixon et al., 2021).

closed using the running subcuticular 6-0 PDS sutures (Ethicon).
Immediately following the surgery, radiographs were used to
conﬁrm that the non-union site remained. Note that the controls
included a sham group where the surgery was completed, but no
scaffold was implanted. All the animals received dox water (1 μg/
ml in 5% sugar water; Sigma) for the duration of the study,
changed weekly. The animals were monitored radiographically
for 2 or 8 weeks after the surgery, chosen from the previous
studies (Douglas et al., 2012; Hao et al., 2016; Orth et al., 2017), to
observe the potential rescue of the non-union site. Following
euthanasia, both the right and left femurs were dissected for
micro-CT and processed for the histological evaluation
(Figures 1B,C).

Adipose-Derived Stem Cell Isolation
In the preparation for scaffold implantation, the subcutaneous
adipose tissue was dissected from 12-week-old WT mice
immediately following euthanasia (CO2 asphyxiation). The
dissected tissue was minced and placed in a digestion solution
(0.1% collagenase and 1% penicillin/streptomycin in Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM)) at 37°C for 1 h. The samples
underwent gentle inversion every 10 min. Following incubation,
the tissue was transferred to a 10 cm culture dish, mechanically
shredded with forceps, and then placed in an incubator for
30 min (37°C and 5% CO2). At this time, the cell suspension
was passed through a 70-µm sterile ﬁlter and centrifuged at
1300 rpm for 10 min at 4°C. The supernatant was removed
and the cell pellet was resuspended in the growth medium
(10% fetal bovine serum (FBS) and 1% penicillin/streptomycin
in DMEM). All the cells were expanded to passage four which has
previously been demonstrated to exhibit greater than 90%
homogeneity for the MSC markers (CD13, CD29, CD44,
CD73, and CD90) (Mitchell et al., 2006; Baer and Geiger,
2012; Dunham et al., 2020). All the adipose-derived stem cells
(ADSCs) were immediately seeded onto the cryogel scaffolds at
passage four for the in vivo implantation.

Radiographic Evaluation
Lateral radiographs were taken weekly following the full fracture
until euthanasia (×3 magniﬁcation, Faxitron UltraFocus100; n =
5–7/group/timepoint). All the radiographs were blindly scored
for the degree of healing using a modiﬁed RUST scoring system
with both the sides of the fracture scored individually and a max
score of 6 total: score = 1 designates only the fracture line is
present, score = 2 is visible callus and fracture line, and score = 3 is
completely bridged with no fracture visible (Cunningham et al.,
2017; Fiset et al., 2018; Thomas and Kehoe, 2021). The mice were
excluded from the study if there was a loss of ﬁxation during
healing or an atrophic non-union was not achieved by week
4 post-fracture (5 mice total).

Micro-Computed Tomography
Following euthanasia, the right and left femurs (n = 5–7/group/
timepoint) were dissected and immediately ﬁxed in 10% NBF for
24 h. After ﬁxation, all the pins were removed from the bone and
ex vivo scans were completed using micro-CT on the right and left
femurs (VivaCT 40, Scanco Medical AG, Switzerland; 10.5 μm
voxel size, 55 kV, 145 μA, 300 ms integration time). For the right
fractured femurs, a 600 slice (6.3 mm length and diameter) ROI
cylinder was centered at the fracture midpoint and thresholds of
180 and 250 per mile was used for 2 and 8 weeks timepoints,
respectively, to segment the total bone (callus + cortical). A highdensity threshold of 460 per mile was then used to segment out
the original cortical bone of all the right (fractured) femurs. The
cortical bone volume was subtracted from the total bone volume
of each sample to determine the volume of new callus bone
formed. In some samples, the fracture lines were no longer visible
due to healing, so the point of fracture was found from the
radiographic images at 0–2 weeks post-fracture (femoral head to
fracture midpoint distance). For the left (intact) femurs, a 100
slice (1.05 mm) ROI was analyzed to compare the systemic
changes due to the surgery or BMP-2 production. Following
scanning, all the femurs were decalciﬁed and processed for
histology.

Scaffold Preparation for Implantation
The cryogel scaffolds were fabricated as described previously in
the Scaffold Fabrication. Three scaffold groups were prepared for
implantation: scaffold only (acellular; no lentivirus), scaffold +
ADSCs transduced to express GFP, and scaffold + ADSCs
transduced to express BMP-2 (n = 5–7/group/timepoint). In
the preparation for implantation, all the scaffolds were seeded
with ADSCs (± lentiviral transduction). Brieﬂy, for the lentiviral
transduction, BMP-2 or GFP lentiviruses were immobilized on
the scaffold and 1 million cells were seeded and transduced, as
described previously in Scaffold Mediated Lentiviral
Transduction. All samples were cultured for 6 days to allow for
cell inﬁltration and proliferation to occur throughout the
cryogels.

Scaffold Implantation
At 4 weeks following the fracture, the achievement of an atrophic
non-union in Col1-tk mice was conﬁrmed via the radiograph. All
the mice were given buprenorphine SR (1 mg/kg, s. c.) for
analgesia 1 h before the surgery. An 8- to 10-mm incision was
created along the previously fractured femur and the muscle was
gently separated from the non-union site, exposing 7 mm of the
femur. The assigned scaffold type (n = 5–7/group/timepoint) was
placed under the femur and wrapped around the non-union such
that the surrounding muscle held the scaffold in place. The
muscle was closed with 4.0 vicryl suture, then the incision was
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Histological Staining and Analysis
Following micro-CT, the samples were decalciﬁed in 14% EDTA
(pH 7.0) for 2 weeks (n = 5–7/group/timepoint). Standard
parafﬁn processing was completed where all the fractured
femurs were sectioned longitudinally at 5 µm thickness. Slides
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from all the samples were stained with picrosirius red/alcian blue
to visualize the different tissues (mineralized callus, cartilage, and
ﬁbrous tissue/other) at the fracture site. Immunohistochemistry
(IHC) was also used to localize the endomucin expression to
evaluate the presence of vasculature throughout the scaffold, as
well as the HSV-tk and GFP expression to identify the role of the
tk+ and GFP+ cells in healing, respectively. To accomplish this,
the parafﬁn slides were ﬁrst deparafﬁnized in xylene and
rehydrated in graded ethanol. Next, incubation with 3% H202
for 5 min blocked the endogenous peroxidases. Note that
proteinase K was used for the antigen retrieval for endomucin
slides prior to blocking (5 min, 23°C). HSV-tk and GFP
endogenous epitopes were blocked with 10% goat serum
(abcam—ab7481) in PBS at RT for 1 h. The sections were
then incubated with rabbit polyclonal anti-HSV tk (1:100; gift
from William Summers, Yale) and rabbit-anti-GFP (1:500; Life
Technologies A11122) overnight at 4°C, followed by a secondary
polymer-HRP anti-rabbit antibody incubation for 1 h (1:200
Dako P0448). The endomucin staining followed the
manufacturer’s instructions (Vectastain Elite ABC kit, Rat IgG
PK-6104) and used the primary antibodies for endomucin (1:400,
eBioV.7C7 #14–5851–85). All the IHC samples were incubated
with DAB chromagen (brown; Vector DAB, SK-4105, 30–45 s)
and counterstained with modiﬁed Mayer’s hematoxylin (Vector
Hematoxylin QS, H-3404). Images were obtained on a
NanoZoomer slide scanner (20x; Hamamatsu Photonics).
Picrosirius Red/alcian blue, HSV-tk, and endomucin images
were blinded and qualitatively assessed for the callus and
scaffold composition.

2017a). To verify the BMP-2 production, following an initial
6 days of culture, the cells were given osteogenic medium ± the
addition of doxycycline (dox; Figure 2B). The non-transduced
and transduced cells that did not receive dox (no dox) had
negligible BMP-2 production over 28 days of culture. Similarly,
a low dose of 0.1 μg/ml of dox was not sufﬁcient to initiate the
detectable BMP-2 production. However, when the transduced
cells were exposed to 1 μg/ml of dox, a signiﬁcantly higher
production of BMP-2 was noted in all the samples which
lasted over 28 days. It should be noted that while there was
some variability in the BMP-2 secretion, these are the biological
replicates. Thus, the seeded constructs may have been of slightly
different sizes, seeded with slightly different numbers of cells, or
received slightly different amounts of virus. Following the culture,
micro-CT was used to quantify the mineralized volume and
density (Figures 2C,D). The transduced cells given 1 μg/ml of
dox and thus, producing BMP-2, had signiﬁcantly more
mineralized volume than the non-transduced cells and
signiﬁcantly higher bone mineral density than the acellular
scaffolds (p < 0.05). Additionally, the transduced cells either
left untreated or supplemented with 0.1 μg/ml of dox also had
signiﬁcantly higher bone mineral density than the acellular
scaffolds (p < 0.05). Note that due to the presence of
osteogenic medium, some mineralized volume and bone
mineral density levels, when the cells are present, are not
unexpected. These results indicate that cryogel scaffolds
support mineralization by the ADSCs in vitro, and that the
mineralized volume is enhanced by the dox-inducible cellular
production of BMP-2.

Statistics

Radiographic Healing Was Improved by the
Presence of Cells

Prior to the experiments, sample sizes for the study were
calculated using a power analysis with α = 0.05 and β= 0.20
(https://www.stat.ubc.ca/~rollin/stats/ssize/n2.html).
The
estimates of sample variance and effect size were based on the
previous data and biological importance (McKenzie et al., 2019).
One-way ANOVA with the Tukey post hoc test was used for
in vitro bone volume and bone mineral density analysis. A chisquare test was used to assess the fracture union based on the
RUST radiographic scoring at 2 and 8 weeks post-scaffold
implantation. Two-way ANOVA with the Tukey post hoc test
was used to correct for multiple comparisons for ex vivo microCT. Signiﬁcance was considered at p-values < 0.05, with trends
noted at p < 0.10. All the data analysis was performed using Prism
(version 9; GraphPad Software, La Jolla, CA, USA).

Blinded scoring of the radiographs was completed weekly until
sacriﬁce at 2 or 8 weeks post-scaffold implantation (6 or 12 weeks
post-fracture; Figure 3). Less than 50% of the animals treated
with either scaffold only or with a sham implantation procedure
showed complete bridging of both the cortices at the fracture site
at 12 weeks. As both the groups consisted of Col1-tk animals
treated with GCV, they were not expected to heal. In comparison,
the scaffolds seeded with GFP+ cells and the scaffolds seeded with
cells producing BMP-2 were the only groups that reached the
complete bridging in all the animals by 12 weeks. Speciﬁcally, the
fractures in all the animals treated with GFP+ scaffolds had
complete bridging (RUST score = 6) after 6 weeks, while over
70% of the BMP-2+ scaffolds were bridged by week 8 and 100%
by week 12. Notably, in all the animals treated with the BMP-2+
scaffolds, mineralization was observed radiographically by week
5–7 (1–3 weeks following implantation) throughout the
implanted scaffold surrounding the fracture site. In
comparison, the GFP+ groups only exhibited mineral within
the scaffold in 2 of the 14 samples at varying timepoints.
There was no signiﬁcant difference between the radiograph
scores of any groups at 6 weeks. However, the radiograph
scores of both the scaffold and sham groups were signiﬁcantly
different than the radiograph scores of both the GFP and BMP-2
groups at 12 weeks. Note that there was no signiﬁcance between

RESULTS
In Vitro Analysis Conﬁrms Cellular
Inﬁltration and BMP-2 Production
The ADSCs were seeded onto the cryogel scaffolds were cultured
for 6 days and then cryosectioned to visualize cell adhesion and
inﬁltration (Figure 2A). As shown by DAPI stain (blue), the
ADSCs were able to inﬁltrate the matrix of all the cryogel
scaffolds in the short window of culture, consistent with prior
results with other cell types (Hixon et al., 2016; Hixon et al.,
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FIGURE 2 | In vitro analysis of the cell-seeded cryogel scaffolds. (A) Representative DAPI (blue) staining demonstrates the ADSCs inﬁltrated throughout the cryogel
scaffold after 6 days of culture. (B) Measured by an ELISA, BMP-2 production was induced in transduced cells treated with 1 μg/ml of dox over 28 days, whereas nontransduced (NT) cells, transduced cells that did not receive dox, and transduced cells that only received 0.1 μg/ml of dox had statistically lower (p < 0.01) BMP-2
production. In transduced cells treated with 1 μg/ml of dox, (C) mineralized volume and (D) bone mineral density were signiﬁcantly higher than those of nontransduced cells and acellular scaffolds, respectively (p < 0.05). The white scale bar denotes 400 µm.

Figure 4B). Three-dimensional reconstructions at this
timepoint also demonstrate mineral formation around the
non-union site within the surrounding scaffold. Additionally,
while the fracture line remains apparent between 2 and 8 weeks in
the majority of the scaffold only and sham groups, the GFP+ and
BMP-2+ cellularized scaffolds exhibited a higher ratio of bridging
and remodeling of the cortical bone between 2 and 8 weeks. We
assessed the skeletal phenotype of the left (intact) femora using
micro-CT and found no signiﬁcance between any groups (p <
0.05; Supplementary Table S1), indicating no systemic
differences between the treatments. In summary, the
cellularized scaffolds promoted bridging at the fracture site,
but only BMP-2+ scaffolds produced a signiﬁcant new bone
surrounding the fracture site.

the sham and scaffold groups or the GFP and BMP-2 groups at
this timepoint (χ2, p < 0.05). In summary, the cellularized
scaffolds promoted the radiographic healing, and the addition
of BMP-2 stimulated the scaffold mineral formation.

Non-Unions Treated With BMP-2+
Cellularized Scaffolds Had Higher Mineral
Content
Following the treatment with scaffolds for 2 or 8 weeks, the
animals were sacriﬁced for micro-CT and histological
evaluation. Ex vivo micro-CT analysis determined the callus
bone volume at both 2 and 8 weeks for all the groups
(Figure 4). Note that the 2 and 8 weeks timepoints had a
threshold at 180 and 250 per mile, respectively, to isolate the
scaffold mineral and thus, cannot be directly compared. At
2 weeks, the BMP-2+ cellularized scaffolds had signiﬁcantly
more bone volume than the acellular scaffold group (p < 0.05)
and also trended higher compared to the sham control (p <
0.0668; Figure 4A). Three-dimensional reconstructions further
demonstrate this, with the mineral formation around the nonunion site and inﬁltrating into the surrounding scaffold. At
8 weeks, the BMP-2+ cellularized scaffolds had signiﬁcantly
more bone volume than all the other groups (p < 0.001;
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Histology Demonstrated Vessels
Throughout the Surrounding Scaffold and
Complete Cortical Bridging With the
Addition of Cellularized Scaffolds
Following the micro-CT analysis of 2-8 weeks samples,
histological evaluation was completed using picrosirius red/
alcian blue stain (Figure 5). At 2 weeks post-sham surgery
(6 weeks post-fracture), the sham control group displayed
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FIGURE 3 | Radiographic scoring of atrophic non-unions treated with sham (no scaffold or cells) control, cryogel (acellular) scaffold only, scaffolds seeded with
GFP+ cells, and scaffolds seeded with cells expressing BMP-2. Due to the treatment with GCV and insufﬁcient rescue, less than 50% of the Col1-tk scaffold only or sham
groups had complete bridging at 12 weeks. Comparatively, the GFP+ and BMP-2+ cells were the only groups to achieve full bridging by week 12, with GFP+ cells
displaying a score of 6 by week 6. Scoring of the radiographs demonstrated no signiﬁcant difference between any groups at 6 weeks. However, there were
signiﬁcant differences between both the sham and scaffold groups as compared to both the GFP and BMP-2 groups at 12 weeks (χ2, p < 0.05). Representative
radiographs are shown from the time of fracture (Week 0) and at 4, 8, and 12 weeks. The BMP-2+ cellularized scaffolds possessed visually mineralized scaffolds
surrounding the non-union site beginning 1–3 weeks following implantation (red arrows) in addition to the endogenous fracture callus (black arrows).

minimal woven bone formation and high levels of ﬁbrous tissue.
After 8 weeks, incomplete healing was still noted in 5 of the 6
samples, despite woven bone formation and some cortical
bridging at all of the fracture sites. Similarly, the scaffold only
treatment displayed some calciﬁed areas with almost no cartilage
present and minimal inﬁltration into the surrounding scaffold,
showing incomplete endochondral bone formation. After
8 weeks, full bridging (denoted by continuous cortical bone)
had visually occurred in 3 of the 7 samples, with the
remaining samples possessing ﬁbrous tissue and minimal
cartilage. In the animals treated with the GFP+ cellularized
scaffolds, new bone was formed at 2 weeks with the presence
of minimal cartilage and ﬁbrous tissue. By 8 weeks
postimplantation, full bridging was achieved in 7 of the 7
samples, with the new bone inﬁltrated into the surrounding
scaffold and no ﬁbrous tissue or cartilage. When the cryogel
scaffolds seeded with the BMP-2-expressing cells were implanted,
cartilage was visualized surrounding the non-union site and
within the surrounding scaffold in 6 of the 7 samples at
2 weeks. After 8 weeks, bridging was visually achieved in all
the samples with the mineral inﬁltrating any surrounding
scaffold still present; no ﬁbrous or cartilage callus tissue was
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observed. In summary, the majority of samples in the sham and
scaffold only groups displayed remnants of the original
fragmented cortical bone with visible fracture surfaces and
lacked complete bridging, whereas the GFP+ and BMP-2+
groups displayed continuous cortical surfaces such that the
fracture line was no longer visible in most samples.
The sections were also stained for endomucin to identify the
presence of vasculature, HSV-tk to localize the tk + cells, and GFP
to discern the role of GFP+ cells in both the endogenous callus at
the non-union site, as well as within the scaffold (Figure 6,
Supplementary Figures S1, S2). Overall, all the groups possessed
a large number of vessels directly at the fracture site and closely
associated with the woven bone formation at 2 weeks
(Figure 6A). After 8 weeks, the vasculature at this site was
greatly reduced with little to no endomucin staining in all the
groups. When the surrounding scaffolds were examined
(Figure 6B), the vessels were visible both within the scaffold
matrix and accompanying the new bone formation at 2 and
8 weeks in all the groups treated with a scaffold ± cells. The new
bone was typically formed on the edges of the scaffold, both
proximal and distal to the fracture site. With respect to the HSVtk staining, the positively stained osteoblasts and osteocytes were
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FIGURE 4 | Ex vivo micro-CT analysis of non-unions treated with sham control, scaffold only, GFP+ cellularized scaffolds, and BMP-2+ cellularized scaffolds at (A)
2 and (B) 8 weeks after repair. The callus bone volume is the threshold total bone—cortical bone. At 2 weeks, the BMP-2+ scaffolds had signiﬁcantly more callus bone
volume than (acellular) the scaffold only (p < 0.05) and trended higher than the sham control (p < 0.0668). At 8 weeks, the BMP-2+ scaffolds had signiﬁcantly more callus
bone volume than all the other groups (p < 0.001). Three-dimensional reconstructions demonstrate that fracture lines are still present in the sham and scaffold
groups at both 2 and 8 weeks, whereas the GFP and BMP-2 groups exhibited increased bridging and remodeling after 8 weeks. Finally, both timepoints exhibited a high
mineral content surrounding the non-union site of the BMP-2+ groups (red arrows).

detected within the bone tissue in some samples from every group
at both 2 and 8 weeks (Supplementary Figure S1). After 8 weeks,
all the BMP-2+ scaffolds also possessed HSV-tk + cells (red
arrows) localized to the new bone formed within the scaffold,
indicating the invasion of host cells. Finally, GFP+ staining was
found within the scaffold around the fracture site at 2 weeks in all
the samples treated with scaffolds seeded with GFP+ cells
(Supplementary Figure S2). However, after 8 weeks, there was
no GFP+ staining in 5 of the 7 samples, with very little staining in
the remaining 2 samples, demonstrating that the GFP+ cells were
no longer present at 8 weeks in the majority of samples.

as the sustained BMP-2 production over 28 days. In vivo,
following implantation at 4 weeks, 50% or less of the animals
treated with either scaffold only or the sham control had a
complete radiographic bridging at 12 weeks. This blunted
healing response was consistent with our previous study that
established the Col1-tk atrophic non-union model (Hixon et al.,
2021). Comparatively, the radiograph analysis showed that the
scaffolds seeded with GFP + cells and the scaffolds seeded with
cells producing BMP-2 were the only groups that reached
complete bridging in all the animals by the end of 12 weeks.
Mineralization was also noted radiographically throughout the
implanted scaffold surrounding the fracture site in all the animals
treated with the BMP-2+ cells. Histologically, it was observed that
the GFP+ and BMP-2+ scaffolds both had woven bone formation
as early as 2 weeks after the implantation, with BMP-2+ scaffolds
displaying both cartilage and woven bone directly at the nonunion site, as well as inﬁltrated into the surrounding scaffold. At
8 weeks after the GFP+ and BMP-2+ scaffold implantation, the
woven bone was noted within the scaffold and the non-union site
had undergone complete bridging as noted by the continuous
cortical bone. Furthermore, the overall addition of a scaffold ±
cells resulted in blood vessel formation, as well as HSV-tk + cells
in the BMP-2 samples, localized to new bone within the scaffold
matrix at 8 weeks. Importantly, in the GFP+ cell group, while the
GFP+ cells were noted histologically at 2 weeks, the majority of

DISCUSSION
We hypothesized that a bioactive cryogel-mediated, doxycyclineinducible lentiviral gene delivery system of BMP-2 would induce
osteogenesis at the atrophic non-union defect site. This approach
was based on the previous studies which demonstrated that
scaffold-mediated gene delivery can induce the sustained
transgene expression and protein synthesis by MSCs (Brunger
et al., 2014; Glass et al., 2014; Moutos et al., 2016; Huynh et al.,
2018; Rowland et al., 2018). Overall, the in vitro data
demonstrated the feasibility of the cryogel-mediated lentiviral
delivery of BMP-2 with adhesion and inﬁltration of cells, as well
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FIGURE 5 | Representative picrosirius red/alcian blue staining of the nonunion site of all groups at 2 and 8 weeks postimplantation. Both the scaffold only and sham
groups displayed early woven bone and ﬁbrous tissue, followed by additional bridging and bone formation between 2 and 8 weeks. At 8 weeks, the callus had some
pockets of woven bone at a still visible fracture site (open arrowheads). While the GFP+ group had some cartilage, it was minimal and resulted in bridging in all animals by
8 weeks. At 2 weeks, 6 of the 7 BMP-2+ groups displayed the cartilage both surrounding the nonunion site and within the surrounding scaffold. After 8 weeks,
bridging was visually achieved in all BMP-2 samples with mineral inﬁltration into the surrounding scaffolds. Cortical bridging was denoted by ﬁlled arrowheads. Scale bars
denote 1 mm. Cg, cartilage; Ct.B, cortical bone; Fb.T, ﬁbrous tissue/other; Ma, marrow; Mu, muscle; Wo.B, woven bone.

samples had no GFP+ cells within the scaffold or around the
fracture site at 8 weeks. This observation indicates that the native
cells were responsible for bone formation seen at 8 weeks, and we
infer that the native cells that were not targeted during the
2 weeks of GCV dosing were activated by the implantation of
the cellularized scaffolds. Overall, the cell-seeded cryogels
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resulted in osseous healing and while the addition of BMP-2
promoted endochondral ossiﬁcation, this appeared to delay
healing contrary to our initial hypothesis. It is possible that
the promotion of endochondral ossiﬁcation may produce a
better functional result in the long term as it mimics normal
fracture healing. However, this should be further investigated
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FIGURE 6 | Representative endomucin (brown) staining of the vasculature within the non-union and scaffold sites of all the groups at 2 and 8 weeks
postimplantation. (A) 10x images of the woven bone at 2 weeks show extensive vessel staining in all the groups (red arrows). Comparatively, at 8 weeks, vessel staining
was greatly reduced in all groups. (B) Endomucin staining within the scaffold showed vasculature associated with new bone formation at both the timepoints in all groups
treated with a scaffold ± cells. Scale bars denote 100 μm.

with future biomechanical testing. Our ﬁndings support further
investigation and development of a cell-seeded tissue engineering
cryogel (±BMP-2) to target speciﬁc timepoints in the clinical nonunion healing process.
Endochondral ossiﬁcation plays a critical role in fracture
repairing and remodeling. This process occurs between the
two fractured ends where the cartilage contributes to a soft
callus to initially stabilize the fracture site. In combination
with intramembranous ossiﬁcation and the formation of a
hard callus, full bridging occurs with the continuous cortical
bone (Marsell and Einhorn, 2011). BMP-2 has been previously
shown to induce chondrogenic differentiation, osteogenic
differentiation, and endochondral ossiﬁcation within the same
system (Zhou et al., 2016). Thus, the expression of BMP-2 not
only encouraged bone formation within the implanted scaffolds
surrounding the fracture site, but also appeared to promote
endochondral ossiﬁcation and bridging at the fracture site.
Notably, cellularized scaffolds without the BMP-2 transfection
also appeared to improve healing at the fracture site, and thus we
are not able to fully attribute the improved healing to the effects of
local BMP-2 production based on this initial study. Future work
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should examine shorter timepoints to identify the windows of
healing as guided by the addition of the scaffold-mediated
lentiviral delivery of BMP-2. This would allow for targeted
healing within an atrophic non-union. Additionally, the
scaffold-mediated lentiviral transduction technique could be
applied to an acellular scaffold to deliver BMP-2 to the nonunion site, encouraging a similar endochondral ossiﬁcation
response without using implanted cells.
The use of the Col1-tk mouse as a model of atrophic nonunion, as well as our scaffold fabrication and implantation
techniques, has several limitations. Our previous study has
demonstrated that 2 weeks of GCV dosing in Col1-tk mice
blunted callus formation and led to a functional non-union at
12 weeks (Hixon et al., 2021). We also observed that via
radiography, in vivo micro-CT, and histology that the fracture
healing response did not change after the ﬁrst 4 weeks in Col1-tk
mice, that is, once the non-union was established, it did not
recover on its own. Thus, we selected the 4-weeks timepoint for
the intervention in the current study. Unexpectedly, we noted
that in some sham and scaffold only samples, there was
radiographic and histological evidence of cortical bridging. It
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is possible that the surgical intervention increased blood ﬂow at
the injury site or otherwise created an environment that
reactivated periosteal cells that were dormant. In addition, the
previous work has demonstrated that muscle-derived stem cells
can differentiate into the cartilage and bone and directly
participate in fracture healing (Liu et al., 2010; Shah et al.,
2013). A short period of GCV dosing following the scaffold
implantation surgery may block the healing due solely to
surgical intervention, providing a more challenging
environment to test the interventions. Regarding the cryogel
scaffolds, these were designed for the ease of handling and cell
seeding in vitro, as well as for the feasibility of surgical
implantation. Yet, the thickness of the scaffolds was large
relative to the femur dimensions, and they showed some
tendency to “unwrap” after the implantation. This resulted in
a diffuse region of mineralization in the BMP-2+ scaffold group.
Additionally, the thick scaffold layer may have hindered the
cellular and vascular inﬁltration of the scaffold, as well as
integration of the scaffold bone with the native callus at the
bone surface. Despite this, 5 of the 7 BMP-2 group had
mineralized scaffold directly integrated with the fully bridged
cortical bone. In the remaining 2 samples, the mineralized
scaffold rested against the bridged fracture site. However, the
cortical bone was continuous with no apparent fracture sites,
demonstrating the overall contribution to healing by the BMP-2+
scaffolds as compared to scaffold only. Future studies will further
optimize the scaffold size and overall placement to minimize
disruption and physical scaffold movement following
implantation. Finally, this study served as a proof-of-concept,
and overall, BMP-2 delivery was not controlled or localized
appropriately. Future work should reconﬁgure the release to
be more localized to the fracture site and target the BMP-2induced endochondral ossiﬁcation, which could be advantageous
to bone healing. In addition to this, it was demonstrated that the
dox-inducible BMP-2 expression can promote endochondral
ossiﬁcation in the cryogel itself which could be optimized
spatially and temporally.
The current clinical practice of non-union often involves
surgical intervention and the use of autologous bone graft.
While the autologous graft is effective in promoting healing,
it requires a second-site surgery and has other limitations/
contraindications including potential infection, donor site
morbidity, and limited availability (Roberts and Rosenbaum,
2012; Sohn and Oh, 2019). Therefore, we selected a tissue
engineering approach that does not use the autologous bone
graft, but does require a surgical intervention, as a ﬁrst step
toward an alternative to current practices. Of interest was the
ﬁnding that the cell-seeded scaffolds may enhance the healing in
atrophic non-unions. Notably, the sham group histologically
closely mirrored the delayed bone bridging and blunted callus
formation as previously shown in our Col1-tk mouse model of
atrophic non-union where no intervention had been employed
(Hixon et al., 2021). In contrast, both the GFP+ and BMP-2+
cellularized cryogel scaffolds resulted in the radiographic
bridging at the site of the non-union. The GFP+ scaffolds
appeared to result in faster healing than the BMP-2+
scaffolds. This could be attributed to the initial high cartilage
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response in the BMP-2+ scaffolds, which may have delayed the
overall healing of the non-union. One of the major downfalls in
treating complex bone defects is a lack of structure and stability
to guide healing. To combat this, tissue engineering scaffolds
provide a unique template that can be tailored to target an
appropriate structure. Combining the tunable delivery of a
biological agent with a scaffold may further enhance healing
in complex atrophic non-unions. In this study, the addition of
cells in combination with the cryogel scaffolds resulted in
cortical bridging, suggesting that cryogels seeded with the
ADSCs (with or without the addition of BMP-2) is a
promising experimental approach to promote the rescue of
the non-union. Future work should include mechanical testing
to directly compare BMP-2+ and GFP+ cellularized scaffolds to
deﬁne the functionality of this rescue technique. Additionally,
as this is a tunable/inducible system, the BMP-2 delivery
window should be further explored to identify if it is
advantageous to include BMP-2 or if solely providing the
cells is sufﬁcient to induce regeneration.
In conclusion, we demonstrated that a cryogel scaffold seeded
with cells enhances fracture healing at a non-union site as
radiographic and histological bridging was achieved in all
animals treated with cell-seeded scaffolds (±BMP-2).
Furthermore, the addition of BMP-2 resulted in cartilage
formation at early timepoints, stimulating the process of
endochondral ossiﬁcation, but slightly delayed overall healing.
Overall, the cryogel scaffolds provided a supportive, porous
matrix for bone ingrowth and new tissue formation. This
research is signiﬁcant as it utilizes a clinically relevant model
of atrophic non-union to evaluate a novel rescue technique to
induce bone formation and promote healing at the non-union
site. These promising initial ﬁndings support the continued
reﬁnement and the study of cellularized cryogels for treating
the non-healing fractures.
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